Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
Methods Mol Biol. 2020;2150:141-152. doi: 10.1007/7651_2019_228.
The thymidine analogues BrdU (5-bromo-2´-deoxyuridine) and EdU (5-ethynyl-2´-deoxyuridine) are routinely used for determination of the cells synthesizing DNA in the S-phase of the cell cycle. Availability of the anti-BrdU antibody clone MoBu-1 detecting only BrdU allowed to develop a method for the sequential DNA labelling by these two thymidine analogues for determining the cell cycle kinetic parameters.In the current step-by-step protocol, we present` two approaches optimized for in vivo study of the cell cycle and the limitations that such approaches imply: (1) determination of the cell flow rate into the G2-phase by dual EdU/BrdU DNA-labelling method and (2) determination of the outflow of DNA-labelled cells arising from the mitosis.
胸腺嘧啶核苷类似物 BrdU(5-溴-2´-脱氧尿苷)和 EdU(5-乙炔基-2´-脱氧尿苷)常用于测定细胞周期 S 期合成 DNA 的细胞。抗 BrdU 抗体克隆 MoBu-1 仅检测 BrdU 的可用性,使得开发这两种胸腺嘧啶核苷类似物的顺序 DNA 标记方法成为可能,用于确定细胞周期动力学参数。在当前的分步方案中,我们提出了两种优化的方法,用于体内研究细胞周期及其所涉及的限制:(1)通过双重 EdU/BrdU DNA 标记方法确定进入 G2 期的细胞流速,以及(2)确定来自有丝分裂的 DNA 标记细胞的流出。